The U.S Food and Drug Administration (FDA) announced this week that it will reevaluate the safety of the controversial hormone replacement medication Prempro. The reassessment, to be conducted by the agency's Center for Drug Evaluation and Research, will determine if the drug's risks (Prempro has been linked to stroke